Nov 05, 2018
It is said old is gold. True indeed! As a case in point, a 150-year-old drug has gained prominence as a potential cancer therapy in the future to bring in much relief to cancer patients. Recently, researchers from the Ohio State University in the USA have found that the drug called Papaverine could make tumours more...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper